Drug Profile
PF 275366
Alternative Names: PF-275366Latest Information Update: 11 Mar 2008
Price :
$50
*
At a glance
- Originator Pfizer
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Sebaceous gland disorders
Most Recent Events
- 20 Dec 2006 Phase-II clinical trials in Sebaceous gland disorders in USA (unspecified route)